Merve Dirikoc

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 2

Top Topics

Small Cell Lung Cancer

Patient Reported

Prognostic Factors

Top Venues

Expert opinion on drug safety

Expert review of molecular diagnostics

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuf Acikgoz, Öznur Bal, Gokhan Ucar, Ayse Durnali, Yakup Ergün, Merve Dirikoc, Selin Akturk Esen, Mutlu Doğan
Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity? Expert opinion on drug safety 20 (5) (2021)
Yakup Ergün, Yusuf Acikgoz, Öznur Bal, Gokhan Ucar, Merve Dirikoc, Eda Caliskan Yildirim, Nadiye Akdeniz, Doğan Uncu
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer. Expert review of molecular diagnostics 19 (12) (2019)